ZELDA MCINTOSH: Open Payments
NPI 1023401866 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 65 payments from 11 companies in 2025. Trend: 2023 $1,031 · 2024 $2,186 · 2025 $1,323
Food & beverage: $1,323
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $337 |
| Teva Pharmaceuticals USA, Inc. | 13 | $266 |
| Lundbeck LLC | 10 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $165 |
| Neurocrine BioSciences, Inc. | 5 | $94 |
| Janssen Pharmaceuticals, Inc | 4 | $75 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
Products named: UZEDY, HETLIOZ, CAPLYTA, FANAPT, REXULTI, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
